A trial for persistent atrial fibrillation using a new ablation technique
Part of Heart & circulation clinical trials.
This trial tests a new type of ablation called PFA for people with persistent atrial fibrillation. It aims to see if targeting heart tissue changes can improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have persistent atrial fibrillation (a type of irregular heartbeat that lasts longer than a week)
- Your left atrium (a heart chamber) must be between 4 and 6 centimeters wide
- You must stop taking most heart rhythm medications (except amiodarone) for at least 5 half-lives before the procedure
- You cannot use beta-blockers or diuretics before or after the ablation
- You cannot have had prior heart surgery or catheter ablation for atrial fibrillation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a newer type of ablation (pulsed field ablation) for people with persistent atrial fibrillation who have already had one ablation. The goal is to see if it can fix the heart rhythm problem again.
This trial tests a new tool called FARAFLEX that uses pulsed electrical energy to treat atrial fibrillation (an irregular heart rhythm). The goal is to see if this method can safely stop AF symptoms in people whose medications haven't worked.
This trial tests a new way to deliver energy (FARAPULSE PFA system) to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to see if these new waveforms can safely and effectively stop AF symptoms and improve quality of life.
This trial tests a new type of ablation (pulsed-field) to treat persistent atrial fibrillation (AFib) that lasts more than 7 days. You may qualify if you have symptoms and haven't had other heart ablation procedures except for one specific type.
This trial compares a newer type of ablation (pulsed field) with the standard radiofrequency ablation for people with persistent atrial fibrillation that hasn't been treated with ablation before. The goal is to see which method works better and has fewer risks.
This trial tests a newer ablation technique called pulsed field ablation to treat atrial fibrillation, a heart rhythm disorder. The goal is to see if this method works well and is safe for patients who need treatment.
Hear when a new Persistent Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.